Vantage logo

US opioid crisis package nears enactment

Medicare is to review ways to encourage use of non-addictive pain relievers, but Heron Therapeutics will miss out on extension of a special payment provision.

Vantage logo
Independent, data-driven daily news and analysis on pharma, biotech and medtech.